Patents by Inventor Hideki Kasuya

Hideki Kasuya has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240082413
    Abstract: As an antitumor drug which is excellent in terms of antitumor effect and safety, there is provided an antibody-drug conjugate in which an antitumor compound represented by the following formula is conjugated to an antibody via a linker having a structure represented by the following formula: -L1-L2-LP-NH—(CH2)n1-La-Lb-Lc- wherein the antibody is connected to the terminal of L1, and the antitumor compound is connected to the terminal of Lc with the nitrogen atom of the amino group at position 1 as a connecting position.
    Type: Application
    Filed: March 3, 2023
    Publication date: March 14, 2024
    Applicant: DAIICHI SANKYO COMPANY, LIMITED
    Inventors: Takeshi MASUDA, Hiroyuki NAITO, Takashi NAKADA, Masao YOSHIDA, Shinji ASHIDA, Hideki MIYAZAKI, Yuji KASUYA, Koji MORITA, Yuki ABE, Yusuke OGITANI
  • Publication number: 20240082300
    Abstract: Provided is a chimeric target factor receptor capable of activating an antigen-presenting cell such as a dendritic cell in a target-factor-specific manner. The chimeric target factor receptor contains a target factor-binding domain, a transmembrane domain, and an intracellular domain containing a TLR intracellular domain.
    Type: Application
    Filed: November 30, 2021
    Publication date: March 14, 2024
    Applicant: NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM
    Inventors: Hideki KASUYA, Yoshinori NAOE, Shigeru MATSUMURA, Ibrahim Ragab Nassr EISSA, Mohamed Abdelmoneim Ahmed ALI MOHAMED
  • Publication number: 20220273739
    Abstract: Provided are a combination drug for treating a malignant tumor, a pharmaceutical composition for treating a malignant tumor, and a pharmaceutical composition for malignant tumor treatment that have an exceptional antitumor effect. A malignant tumor can be treated by a combination drug containing a first medicine that includes an oncolytic virus belonging to the herpes simplex viruses type 1 as an active ingredient, and a second medicine that includes an interferon gene stimulating factor agonist as an active ingredient.
    Type: Application
    Filed: July 30, 2020
    Publication date: September 1, 2022
    Inventors: Hideki KASUYA, Yoshinori NAOE, Shigeru MATSUMURA, Ibrahim Ragab Nassr EISSA
  • Publication number: 20030088417
    Abstract: A speech segment to be analyzed is cut out with a window having a length of a plurality of pitch periods for RK model voicing source parameter estimation. GCIs are all estimated for a plurality of voicing source pulses. Based on such estimations, an RK model voicing source waveform is generated, its relationship with the speech segment is analyzed by ARX system identification, and then a glottal transform function is estimated. While this process repeated, when GCIs converge at a predetermined value, the identification is completed. Accordingly, a high quality analysis-synthesis system, which isolates voicing source parameters of speech signals from vocal tract parameters thereof with high accuracy, can be realized.
    Type: Application
    Filed: September 19, 2001
    Publication date: May 8, 2003
    Inventors: Takahiro Kamai, Yumiko Kato, Hideki Kasuya, Takahiro Ohtsuka
  • Patent number: 5701349
    Abstract: An active vibration controller includes acceleration detectors for generating output signals on the basis of vibrations of a vehicle, speakers provided in a vehicle's cabin, microphones provided in the vehicle's cabin for receiving generated sounds from the speakers and road noises generated on the basis of running of the vehicle, and adaptive digital filters using output signals from the acceleration detectors as inputs for controlling filter factors on the basis of an RLS algorithm to minimize levels of output signals from the microphones in response to output signals from the microphones and output signals from the acceleration detectors through use of a transfer function matched to the transfer function of the vehicle's cabin in a sound field between the speakers and the microphones. The controller minimized levels of output signals from the microphones by developing an applied output signal to the speakers.
    Type: Grant
    Filed: June 7, 1995
    Date of Patent: December 23, 1997
    Assignee: Hokda Giken Kogyo Kabushiki Kaisha
    Inventors: Hisashi Sano, Sou Nakamura, Hideshi Sawada, Shuichi Adachi, Hideki Kasuya
  • Patent number: 4405838
    Abstract: A phoneme information extracting apparatus includes correlation data generators for successively generating correlation data representing the correlation between the acoustic power spectrum data corresponding to input voice and power spectrum data of various reference phonemes, selection circuits for successively transferring these correlation data when they detect that three or more successive correlation data have values greater than a predetermined value, maximum data hold circuits for holding the maximum correlation data among the correlation data transferred from the respective selection circuits, and a phoneme determination circuit for determining the optimum phoneme by detecting one of the data hold circuits that is holding the maximum correlation data among the correlation data held in the data hold circuits.
    Type: Grant
    Filed: June 15, 1981
    Date of Patent: September 20, 1983
    Assignee: Tokyo Shibaura Denki Kabushiki Kaisha
    Inventors: Tsuneo Nitta, Hideki Kasuya